Google Deepmind has unveiled the third major version of its "AlphaFold" artificial intelligence model, designed to help scientists design drugs and target disease more effectively. In 2020, the company made a significant advance in molecular biology by using AI to successfully predict the behaviour of microscopic proteins. With the latest incarnation of AlphaFold, researchers at DeepMind and sister company Isomorphic Labs – both overseen by cofounder Demis Hassabis – have mapped the behaviour... Read this story at Drudge Report , ETtech.com